Allan S. Wagman
Corporate Officer/Principal chez RAIN ONCOLOGY INC.
Postes actifs de Allan S. Wagman
Sociétés | Poste | Début | Fin |
---|---|---|---|
RAIN ONCOLOGY INC. | Corporate Officer/Principal | 01/07/2018 | - |
Historique de carrière de Allan S. Wagman
Anciens postes connus de Allan S. Wagman
Sociétés | Poste | Début | Fin |
---|---|---|---|
SAGIMET BIOSCIENCES INC. | Corporate Officer/Principal | 01/05/2013 | 01/07/2018 |
Blanca Pharmaceuticals LLC | Corporate Officer/Principal | 01/10/2012 | 01/11/2015 |
ACHAOGEN | Corporate Officer/Principal | 01/10/2006 | 01/04/2013 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formation de Allan S. Wagman
Carnegie Mellon University | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Corporate Officer/Principal | 5 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SAGIMET BIOSCIENCES INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Blanca Pharmaceuticals LLC | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- Allan S. Wagman
- Expérience